Stay up to date

Mapped Outbreak Data

Read current official WHO and CDC news updates, listed below in the Newsfeeds section, descending from the most recent on top. See the notices from both organizations mapped globally immediately below.**

**Refresh if the map does not load immediately. Please note, not all news items map. See the news feeds below also.


WHO Disease Outbreaks

  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 13 Dec 2018
    The Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo is occurring in an unforgiving context. Non-engagement from communities and conflict continue to hamper response activities in some affected areas. Moreover, poor infection prevention and control (IPC) practices across numerous private and public health centers remain a major source of amplification of the outbreak and risk to health and other frontline workers.

    Despite these challenges, substantial progress has been made on multiple fronts to address the situation, and daily successes are being observed in the implementation of proven public health measures alongside newer tools, such as vaccination and novel therapeutics. Together with the Ministry of Health (MoH) and our partners, WHO is further scaling up our response to the developing situation. WHO especially emphasizes the need to continuously improve quality, judiciously deploy new tools at our disposal, and sustain international commitment to response efforts well into 2019. Nonetheless, we remain confident the outbreak can be brought to a conclusion.
  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 06 Dec 2018
    Responding to the Ebola virus disease (EVD) outbreak in north-eastern parts of the Democratic Republic of the Congo continues to be a multifaceted challenge. By utilising proven public health measures (contact tracing, engaging communities) as well as new tools at hand (vaccine and therapeutics), WHO remains confident the outbreak can be contained and brought to an end.

    During the reporting period (28 November – 4 December 2018), 35 new cases were reported from nine health zones in North Kivu and Ituri provinces: Beni (8), Komanda (eight), Katwa (eight), Vuhovi (three), Kalunguta (two), Butembo (two), Mabalako (two), Masereka (one), and Mutwanga (one). Recent cases in Komanda and Mabalako health zones follow an extended period (exceeding two incubation periods) without detection of new cases; highlighting the risk of reintroduction of the virus, and the need to maintain enhanced surveillance. Cases in the Komanda originated from an infection of a mother and her children in Beni. While insecurity in Komanda will challenge the response activities, control measures including contact tracing and vaccination were initiated soon after the detection of cases.
  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 29 Nov 2018
    As the Ebola virus disease (EVD) outbreak approaches five months since declaration, responding to the outbreak continues to be a challenge; nevertheless, in collaboration with the Ministry of Health (MoH) and partners, WHO remains focused on the ongoing containment efforts to end the outbreak.

CDC Travel Notices:


Click here to search for travel related diseases by country.

The Travel Clinical Assistant (TCA) is by the Georgia Department of Health.


CDC Morbidity and Mortality Weekly Report (MMWR):


Current Journal Updates

Clinical Infectious Diseases Journal

This list includes items from the latest issue of the Clinical Infectious Diseases Journal.

Listen: New England Journal of Medicine

The New England Journal of Medicine is a weekly general medicine journal, and this audio news feed presents interviews with specialists.

  • NEJM Interview: Dr. David Morens on lessons from the 1918 influen...
    Wed, 12 Dec 2018
    Dr. David Morens is senior advisor to the director of the National Institute of Allergy and Infectious Diseases. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.M. Morens and J.K. Taubenberger. Influenza Cataclysm, 1918. N Engl J Med 2018;379:2285-2287.
  • NEJM Interview: Dr. David Jones on the possibilities for finding ...
    Wed, 05 Dec 2018
      Dr. David Jones is an assistant professor of health policy and management at the Boston University School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.K. Jones, C. Pagel, and C.F. Koller. The Future of Health Care Reform — A View from the States on Where We Go from Here. N Engl J Med 2018;379:2189-91.  
  • NEJM Interview: Dr. Eve Rittenberg on providing patient-centered ...
    Wed, 28 Nov 2018
      Dr. Eve Rittenberg is a primary care physician at Brigham and Women’s Hospital’s Fish Center for Women’s Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. E. Rittenberg. Trauma-Informed Care - Reflections of a Primary Care Doctor in the Week of the Kavanaugh Hearing. N Engl J Med 2018;379:2094-5. D.R. Novick. Sit Back and Listen - The Relevance of Patients’ Stories to Trauma-Informed Care. N Engl J Med 2018;379:2093-4.  

Emerging Infectious Diseases Journal:

This list contains articles published online ahead of print.


Center for Infectious Disease Research and Policy:

News from the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP).

Johns Hopkins Medicine RSS Feed:

Johns Hopkins Medicine science and medical news.

  • Study Shows Increased Risk of Uterine Fibroids in African-America...
    Thu, 28 Dec 2017
    In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids.
  • More Tumor Mutations Equals Higher Success Rate With Cancer Immun...
    Wed, 20 Dec 2017

    The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows. The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs.

  • How Electroconvulsive Therapy Relieves Depression Per Animal Expe...
    Mon, 18 Dec 2017
    In a study using genetically engineered mice, Johns Hopkins researchers have uncovered some new molecular details that appear to explain how electroconvulsive therapy (ECT) rapidly relieves severe depression in mammals, presumably including people. The molecular changes allow more communication between neurons in a specific part of the brain also known to respond to antidepressant drugs.

American Journal of Infection Control:

RSS feed including 'the latest published articles, both published in an issue and published as Articles in Press.'

  • Universal staphylococcal decolonization for elective surgeries: ...
    Staphylococcal decolonization decreases the risk of Staphylococcus aureus surgical site infection. This study evaluates patient perceptions and barriers to a universal Staphylococcal decolonization (USD) protocol.
  • The emerging role of the corporate or system-level infection pre...
    One position in integrated delivery networks (IDNs) that provides centralized oversight to optimize patient safety is the corporate-level infection prevention (IP) director. After noting variability in their roles, responsibilities, and IP programs, a national network of IDN IP directors planned a member survey to better understand common and variable elements. Nine network members volunteered to design a survey to describe the current role, responsibilities, and resourcing of all members of the corporate IP director group.
  • Risk factors for infection in spine surgery: Nested case-control...
    We read with interest the article by Gu et al,1 “Incidence and Risk Factors for Infection in Spine Surgery: A Prospective Multicenter Study of 1764 Instrumented Spinal Procedures.” In this prospective multicenter study, Gu et al1 included patients (≥18 years old) who had spinal diseases treated by instrumented surgery between January 2015 and February 2016. Their study showed that 58 patients (3.3% of the population) had developed a surgical site infection (SSI) and that the main risk factor for an SSI in this population was the reason for surgery (degenerative disease).